Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2057-3804
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Juvenile competitive triathlete after cardiotoxic anthracycline therapy for Acute Myeloid Leukemia ; volume:2 ; number:1 ; day:14 ; month:10 ; year:2016 ; pages:1-4 ; date:12.2016
Cardio-Oncology ; 2, Heft 1 (14.10.2016), 1-4, 12.2016
- Urheber
-
von Korn, Pia
- Beteiligte Personen und Organisationen
-
Vogt, Manfred
Oberhoffer, Renate
Ewert, Peter
Müller, Jan
SpringerLink (Online service)
- DOI
-
10.1186/s40959-016-0016-0
- URN
-
urn:nbn:de:1111-2016111329354
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- von Korn, Pia
- Vogt, Manfred
- Oberhoffer, Renate
- Ewert, Peter
- Müller, Jan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Current treatment of juvenile myelomonocytic leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Current developments in acute myeloid leukemia
CDK9 inhibitors in acute myeloid leukemia
FLT3 inhibitors in acute myeloid leukemia
Chronic Myeloid Leukemia Preceded by Tuberculosis
Treatment of Relapsed Acute Myeloid Leukemia
Precision therapy for acute myeloid leukemia
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Current treatment of juvenile myelomonocytic leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Current developments in acute myeloid leukemia
CDK9 inhibitors in acute myeloid leukemia
FLT3 inhibitors in acute myeloid leukemia
Chronic Myeloid Leukemia Preceded by Tuberculosis
Treatment of Relapsed Acute Myeloid Leukemia
Precision therapy for acute myeloid leukemia
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
Pregnancy with acute myeloid leukemia
Chronic myeloid leukemia in India
Current treatment of juvenile myelomonocytic leukemia
Immunogenicity of leukemia stem cells in acute myeloid leukemia
Current developments in acute myeloid leukemia
CDK9 inhibitors in acute myeloid leukemia
FLT3 inhibitors in acute myeloid leukemia
Chronic Myeloid Leukemia Preceded by Tuberculosis
Treatment of Relapsed Acute Myeloid Leukemia